Huntington National Bank’s Adaptive Biotechnologies ADPT Stock Holding History

Huntington National Bank’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11K	Hold	52	–	–	﹤0.01%	2547
2026 Q1	$722	Buy	52 +51	+5,100%	+$813	﹤0.01%	2406
2025 Q4	$16	Hold	1	–	–	﹤0.01%	3494
2025 Q3	$15	Hold	1	–	–	﹤0.01%	3556
2025 Q2	$12	Hold	1	–	–	﹤0.01%	3646
2025 Q1	$7	Hold	1	–	–	﹤0.01%	3802
2024 Q4	$6	Hold	1	–	–	﹤0.01%	3847
2024 Q3	$5	Hold	1	–	–	﹤0.01%	3876
2024 Q2	$4	Hold	1	–	–	﹤0.01%	3852
2024 Q1	$3	Hold	1	–	–	﹤0.01%	3757
2023 Q4	$5	Sell	1 -515	-100%	-$2.35K	﹤0.01%	3599
2023 Q3	$2.81K	Sell	516 -273	-35%	-$1.8K	﹤0.01%	1970
2023 Q2	$5.29K	Buy	789 +700	+787%	+$5.21K	﹤0.01%	1784
2023 Q1	$786	Sell	89 -47	-35%	-$414	﹤0.01%	2053
2022 Q4	$1.04K	Buy	136 +53	+64%	+$412	﹤0.01%	1842
2022 Q3	$0	Buy	+83	New	+$782	﹤0.01%	1973
2020 Q3	–	Sell	-3	Closed	–	–	1506
2020 Q2	$0	Buy	+3	New	+$109	﹤0.01%	1479

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Huntington National Bank's ADPT Position: Q2 2026 in Review

Huntington National Bank held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 52 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #2547.

Huntington National Bank first reported a position in ADPT in Q2 2020 and has held it in 17 quarters since. The position peaked at $5.29K in Q2 2023. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Huntington National Bank held 52 shares of Adaptive Biotechnologies worth $1.11K as of Q2 2026.
Huntington National Bank left its Adaptive Biotechnologies share count unchanged in Q2 2026.
Adaptive Biotechnologies made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #2547 holding.
Huntington National Bank first reported a position in Adaptive Biotechnologies in Q2 2020 and has held it in 17 quarters since.
Huntington National Bank's Adaptive Biotechnologies position peaked at $5.29K in Q2 2023.
300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.